Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thymoma × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 52 Carcinoma, Renal Cell 47 Neoplasm Metastasis 24 Neoplasms 18 Kidney Neoplasms 18 Neuroendocrine Tumors 17 Carcinoma, Non-Small-Cell Lung 13 Tuberous Sclerosis 12 Stomach Neoplasms 12 Lymphoma, Mantle-Cell 12 Lymphoma, Large B-Cell, Diffuse 11 Recurrence 10 Prostatic Neoplasms 10 Lymphoma 10 Hodgkin Disease 10 Glioblastoma 10 Colorectal Neoplasms 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Brain Neoplasms 9 Lymphoma, Follicular 8 Lung Neoplasms 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Carcinoma 8 Waldenstrom Macroglobulinemia 7 Triple Negative Breast Neoplasms 7 Sarcoma 7 Multiple Myeloma 7 Lymphoma, B-Cell, Marginal Zone 7 Glioma 7 Central Nervous System Neoplasms 7

Interventions

Sunitinib 3 Thymectomy 2 Taxes 2 Prednisone 2 Pemetrexed 2 Paclitaxel 2 Octreotide 2 Imatinib Mesylate 2 Erlotinib Hydrochloride 2 Cisplatin 2 Carboplatin 2 vorolanib 1 regorafenib 1 pembrolizumab 1 olaparib 1 lenvatinib 1 entinostat 1 bosutinib 1 belinostat 1 atezolizumab 1 anetumab ravtansine 1 amrubicin 1 Ramucirumab 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Psychiatric Rehabilitation 1 Prednisolone 1 Patient Comfort 1 Palliative Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02049047 2022-09-10

ONC-2010-001

Istituto Clinico Humanitas

Phase 2 Completed

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡